These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35511648)

  • 1. [ALK-HOOK1-rearranged renal cell carcinoma: report of a case].
    Xu AD; Fu Y; Zhao XS; Fan X
    Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):464-466. PubMed ID: 35511648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review.
    Kathuria-Prakash N; Lopez LP; Raman S; Ye H; Anaokar J; Sisk A; Pantuck AJ; Drakaki A
    JCO Precis Oncol; 2024 Jun; 8():e2400154. PubMed ID: 38885453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
    Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
    Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-rearranged renal cell carcinomas in Polish population.
    Gorczynski A; Czapiewski P; Korwat A; Budynko L; Prelowska M; Okon K; Biernat W
    Pathol Res Pract; 2019 Dec; 215(12):152669. PubMed ID: 31677810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner.
    Gupta S; Krishna M; Cheville JC
    Hum Pathol; 2024 Jul; 149():75-76. PubMed ID: 38670236
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
    Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
    Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
    Hang JF; Chung HJ; Pan CC
    Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
    Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STRN::ALK fusion renal cell carcinoma with lung metastasis: report of a case].
    Xian J; Yin XX; Wang DH; Zhang MX; Zheng LM; Zhou Q; Chen N
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):631-633. PubMed ID: 38825915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic response to alectinib in a patient with ALK-rearranged squamous cell lung cancer.
    Shiihara J; Ohyanagi F; Amari H; Toda M; Tahara H; Yuzawa M; Maeda Y; Nomura M; Mizushina Y; Nagai Y; Ohta H; Yamaguchi Y
    Thorac Cancer; 2021 Sep; 12(17):2420-2423. PubMed ID: 34324792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
    Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
    Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: A Case Report of a Histological Transformation of
    Zhang Y; Qin Y; Xu H; Yao Q; Gao Y; Feng Y; Ren J
    Pathol Oncol Res; 2021; 27():637745. PubMed ID: 34257603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoregulin-Anaplastic Lymphoma Kinase (ALK), a Novel ALK Rearrangement That Responds to Crizotinib in Lung Adenocarcinoma.
    Wang L; Yao S; Teng L; Zhang W; Chen L
    J Thorac Oncol; 2020 Mar; 15(3):e44-e46. PubMed ID: 32093861
    [No Abstract]   [Full Text] [Related]  

  • 15. Superficial ALK-rearranged myxoid spindle cell neoplasm with a novel FMR1-ALK fusion gene.
    Kao YC; Lee PH; Wu CL; Yu SC; Huang HY
    Mod Pathol; 2022 Mar; 35(3):438-441. PubMed ID: 34937902
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer.
    Wang W; Sun X; Hui Z
    Oncol Res Treat; 2019; 42(11):599-606. PubMed ID: 31527380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
    Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
    Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.
    Cajaiba MM; Jennings LJ; George D; Perlman EJ
    Genes Chromosomes Cancer; 2016 Oct; 55(10):814-7. PubMed ID: 27225638
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
    Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.
    Iannantuono GM; Riondino S; Sganga S; Roselli M; Torino F
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.